Daptomycin-Induced Acute Renal and Hepatic Toxicity Without Rhabdomyolysis
Authors:
- 15 April 2008
- journal article
- case report
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 42 (5) , 719-721
Abstract
Objective: To report a case of a patient who experienced acute renal and hepatic toxicity following administration of daptomycin and review previously published case reports of renal and hepatic dysfunction with daptomycin. Case Summary: A 35-year-old man receiving daptomycin 4 mg/kg (275 mg) intravenously once daily (started 5 wk prior to presentation for presumed osteomyelitis) presented to the emergency department with elevations in serum creatinine and hepatic transaminase levels. He did not experience creatine kinase (CK) elevation or rhabdomyolysis. Following discontinuation of daptomycin, his renal and hepatic function improved. Discussion: To our knowledge, this is the first case of daptomycin-induced hepatotoxicity with acute renal failure in the absence of rhabdomyolysis and CK abnormalities. Previously published case reports described patients with a variety of elevations in liver function tests, serum creatinine, and CK with daptomycin. In our patient, the acute renal and hepatic toxicity was probable according to the Naranjo probability scale. Conclusions: Although daptomycin is a well-tolerated antibacterial agent, clinicians should consider periodic monitoring of liver function and renal function tests to identify potential adverse effects.Keywords
This publication has 9 references indexed in Scilit:
- Early-onset rhabdomyolysis related to daptomycin useInternational Journal of Antimicrobial Agents, 2007
- DaptomycinDrugs, 2007
- Early-onset Rhabdomyolysis Associated With DaptomycinInfectious Diseases in Clinical Practice, 2006
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Rhabdomyolysis during Therapy with DaptomycinClinical Infectious Diseases, 2006
- Rhabdomyolysis and acute renal failure in a patient treated with daptomycinJournal of Antimicrobial Chemotherapy, 2006
- Severe myopathy and possible hepatotoxicity related to daptomycinJournal of Antimicrobial Chemotherapy, 2005
- Muscle Pain Associated with DaptomycinAnnals of Pharmacotherapy, 2004
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981